Discovery of De Novo Macrocyclic Peptides by Messenger RNA Display
Author:
Funder
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science London
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference85 articles.
1. Macrocyclic peptides as drug candidates: recent progress and remaining challenges;Vinogradov;J. Am. Chem. Soc.,2019
2. Macrocycles: lessons from the distant past, recent developments, and future directions;Yudin;Chem. Sci.,2015
3. Cyclic peptide therapeutics: past, present and future;Zorzi;Curr. Opin. Chem. Biol.,2017
4. Targeting protein–protein interfaces using macrocyclic peptides;Gao;Biopolymers,2015
5. Cyclic and macrocyclic peptides as chemical tools to recognise protein surfaces and probe protein–protein interactions;Cardote;Chemmedchem,2016
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemical Stability of mRNA/cDNA Complexes: Defining the Limits of mRNA display;Chemistry – An Asian Journal;2024-09-03
2. PepExplainer: An explainable deep learning model for selection-based macrocyclic peptide bioactivity prediction and optimization;European Journal of Medicinal Chemistry;2024-09
3. Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking;2024-08-25
4. Discovery of Thioether-Cyclized Macrocyclic Covalent Inhibitors by mRNA Display;Journal of the American Chemical Society;2024-08-13
5. Ribosomal Incorporation of Lithocholic Acid into Peptides for the De Novo Discovery Of Peptide-Lithocholic Acid Hybrid Macrocyclic Peptides;ACS Chemical Biology;2024-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3